In the BioHarmony Drug Report Database

"Preview" Icon

Teriflunomide

Aubagio (teriflunomide) is a small molecule pharmaceutical. Teriflunomide was first approved as Aubagio on 2012-09-12. It is used to treat relapsing-remitting multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis. The pharmaceutical is active against dihydroorotate dehydrogenase (quinone), mitochondrial. Aubagio’s patents are valid until 2034-02-04 (FDA).

 

Trade Name

 

Aubagio
 

Common Name

 

teriflunomide
 

ChEMBL ID

 

CHEMBL973
 

Indication

 

multiple sclerosis, relapsing-remitting multiple sclerosis
 

Drug Class

 

Image (chem structure or protein)

Teriflunomide structure rendering